__NUXT_JSONP__("/drugs/Eltrapuldencel-T", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:b,chebiId:b,chemicalFormula:b,definition:"A therapeutic melanoma vaccine consisting of autologous dendritic cells (DCs) pulsed with antigens from lethally irradiated autologous tumor cells derived from a patient-specific, continuously proliferating and melanoma-initiating cell line and suspended in a solution containing the cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulatory and antineoplastic activities. Upon subcutaneous administration, eltrapuldencel-T may stimulate the immune system to exert a cytotoxic T-lymphocyte (CTL) immune response against the patient's repertoire of melanoma-associated antigens, particularly tumor stem cell antigens, found in the irradiated autologous cancer cells. As an immunostimulant, GM-CSF enhances the activation of dendritic cells (DCs) and promotes antigen presentation to both B- and T-lymphocytes.",fdaUniiCode:"M2LBQ7RN2X",identifier:"C120183",preferredName:a,semanticType:"Cell",subclassOf:["C2594"],synonyms:["Autologous DCs Loaded with Irradiated Autologous Tumor Cells in GM-CSF","Autologous Dendritic Cells Loaded with Irradiated Autologous Tumor Cells in Granulocyte-macrophage Colony-stimulating Factor","DC-TC","ELTRAPULDENCEL-T",a,"Melapuldencel-T","NBS-20","NBS20"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FEltrapuldencel-T",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Eltrapuldencel-T","","2021-10-30T13:19:59.043Z")));